A share price of Edwards Lifesciences Corp [EW] is currently trading at $84.84, down -0.56%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EW shares have gain 1.10% over the last week, with a monthly amount glided 0.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on November 03, 2025, when Raymond James upgraded its rating to an Outperform but kept the price target unchanged to $96 for it. Previously, Wolfe Research upgraded its rating to Peer Perform on October 29, 2025. On October 29, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $98 on the stock. Oppenheimer downgraded its rating to a Perform. Evercore ISI upgraded its rating to an Outperform but $88 remained the price target by the analyst firm on October 07, 2025. BTIG Research upgraded its rating to Buy for this stock on July 29, 2025, but kept the price target unchanged to $100. In a note dated April 24, 2025, Piper Sandler upgraded an Overweight rating on this stock but restated the target price of $80.
Edwards Lifesciences Corp experienced fluctuations in its stock price throughout the past year between $65.94 and $87.89. Currently, Wall Street analysts expect the stock to reach $95.2 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $84.84 at the most recent close of the market. An investor can expect a potential return of 12.21% based on the average EW price forecast.
Analyzing the EW fundamentals
Trailing Twelve Months sales for Edwards Lifesciences Corp [NYSE:EW] were 5.88B which represents 14.67% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.27%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.13 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 84.28 points at the first support level, and at 83.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 85.80, and for the 2nd resistance point, it is at 86.75.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Edwards Lifesciences Corp [NYSE:EW] is 4.00. As well, the Quick Ratio is 3.29, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 8.37, the price to book ratio is 4.83 and price to earnings (TTM) ratio is 36.12.
Transactions by insiders
Recent insider trading involved BOBO DONALD E JR, CVP,Strategy/Corp Development, that happened on Dec 12 ’25 when 11386.0 shares were sold. CVP, JAPAC, Lippis Daniel J. completed a deal on Dec 12 ’25 to sell 1019.0 shares. Meanwhile, Director STONE HEISZ LESLIE sold 2615.0 shares on Dec 12 ’25.
